Please login to the form below

Not currently logged in
Email:
Password:

Tiziana Life Sciences

This page shows the latest Tiziana Life Sciences news and features for those working in and with pharma, biotech and healthcare.

Shire strikes bi-specific antibody deal with Novimmune

Shire strikes bi-specific antibody deal with Novimmune

A.”. The financials of the deal were not disclosed, but the partnership brings about good news for Novimmune, who also has deals in place with Tiziana Life Sciences and Roche.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Taking a lean and careful approach Taking a lean and careful approach

    Kunwar Shailubhai on why biotech is a roller coaster and how Tiziana Life Sciences is pursuing its mission to tackle unmet needs. ... At 58 years old, he is still shuttling between the US and the UK as the London-based company, Tiziana Life Sciences,

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences

    London, UK-based biotechnology group Tiziana Life Sciences has appointed its non-executive director Dr Kunwar Shailubhai as chief executive officer and chief scientific officer. ... He said: “This is a crucial time to be taking on this new role with

  • Tiziana Life Sciences appoints clinical sciences VP Tiziana Life Sciences appoints clinical sciences VP

    Dr Robert Evans joins the UK biotechnology firm. London-based Tiziana Life Sciences has appointed Dr Robert Evans as its new vice president of clinical sciences. ... James Tripp, chief operating officer at Tiziana Life Sciences, said: “Bob's extensive

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics